| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2006 | 2006 | ||||||||
|
ATP binding cassette subfamily D member 1 | 0.563 | 0.731 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 1998 | 1998 | ||||||||
|
contactin associated protein 1 | 0.554 | 0.577 | 3.4E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
cyclin dependent kinase 13 | 0.606 | 0.692 | 0.91 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
peroxisomal biogenesis factor 1 | 0.538 | 0.769 | 1.1E-14 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
actin alpha 2, smooth muscle | 0.508 | 0.846 | 0.93 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RAD51 recombinase | 0.447 | 0.846 | 2.7E-02 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
ribosomal protein S6 kinase A3 | 0.491 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
piezo type mechanosensitive ion channel component 2 | 0.529 | 0.769 | 8.1E-07 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
nuclear receptor binding SET domain protein 1 | 0.505 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
SKI proto-oncogene | 0.503 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
bone morphogenetic protein receptor type 1A | 0.522 | 0.731 | 0.90 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | 0.527 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
spermine synthase | 0.491 | 0.846 | 0.97 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
TATA-box binding protein associated factor 1 | 0.581 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
peroxisomal biogenesis factor 5 | 0.561 | 0.731 | 5.6E-05 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
Bardet-Biedl syndrome 1 | 0.593 | 0.692 | 3.4E-12 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
ATPase copper transporting alpha | 0.494 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
BCL6 corepressor | 0.471 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
VAC14 component of PIKFYVE complex | 0.588 | 0.731 | 0.19 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
intraflagellar transport 122 | 0.560 | 0.846 | 2.4E-24 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
ER membrane associated RNA degradation | 0.647 | 0.538 | 5.8E-16 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
protein kinase cGMP-dependent 1 | 0.603 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 |